All medicines centrally authorised in the EU (EMA)
Aumolertinib mesilate
bempedoic acid;ezetimibe
bempedoic acid
cabozantinib (s)-malate
A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022, CVR-167) A/Massachusetts/18/2022 (H3N2)-like strain (A/Sydney/1304/2022, wild type) B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type)
febuxostat
lenacapavir sodium
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) / A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022 IVR-237) / B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) / B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B) influenza virus
denosumab
donanemab
eltrombopag
rimegepant
aflibercept
Epizootic hemorrhagic disease virus, serotype 8, VP2 protein
asenapine maleate
roflumilast
ioflupane (123l)
ranibizumab
pegfilgrastim
rivastigmine
Page 38 of 134 • 20 of 2,678 Medicines